Workflow
会展服务
icon
Search documents
中原国际会展中心:硬件、政策与布局三位一体铸就会展新高地
Zhong Guo Jing Ji Wang· 2025-12-25 11:09
由德国GMP与英国罗杰斯两大国际顶尖建筑事务所联袂设计,实现功能与颜值的双重提升。该展 馆已成功承接第三届全国技能大赛、世界机器人大赛、中欧班列博览会等一系列高规格赛事与展会,其 中第三届全国技能大赛作为"规格最高、项目最多、规模最大"的国家级职业技能赛事,其顺利举办充分 印证了展馆的承载能力与服务水平,彰显了"国家流动大展首选地"的硬件底气。 中原国际会展中心外景 中原国际会展中心二期外景 中原国际会展中心地处郑州航空港经济综合实验区(简称河南郑州航空港),这里既是由国务院批复 设立的国家级航空港经济发展先行区,也是郑州—卢森堡"空中丝绸之路"先导区。 以规模化布局与专业化配置筑牢竞争根基,中原国际会展中心的硬件实力稳居全国前列。展馆32个 展厅均采用无柱设计,层高最高可达18米,单厅电力配置最高达4000KVA,具备承接高端精品展、超 大型工业展等多元展会的灵活适配能力。 32万平方米、地处国家级航空港区,作为今年国内全面投入使用的会展中心里规模最大的一座,中 原国际会展中心凭借多方优势跻身全国顶尖会展场馆行列,不仅是河南和中部会展经济崛起的强力引 擎,也为全国会展业发展提供了高品质的新载体。如今,这座承 ...
米奥会展:已于2025年12月24日向香港联交所递交H股发行申请
Guo Ji Jin Rong Bao· 2025-12-25 10:09
米奥会展公告,公司已于2025年12月24日向香港联合交易所有限公司递交了发行境外上市股份(H股)并 在香港联交所主板挂牌上市的申请,并于同日在香港联交所网站刊登了本次发行并上市的申请资料。 ...
全球展台设计与搭建服务商精选——优质服务商解析
Sou Hu Cai Jing· 2025-12-25 09:02
2025年,中国会展市场继续呈现稳健复苏态势,整体规模已跃升至千亿级别。然而,设计风格趋同、施 工品质不一等行业痛点,仍直接影响着参展效果的实际达成。根据国际展览业协会与中国会展经济研究 机构近期发布的调研报告,目前仅约三成的搭建服务商同时具备国际认证资质、大型项目实战经验与体 系化售后支持能力,企业在筛选合作方时依然面临较大挑战。 为帮助企业更精准地选定可靠合作伙伴,本次评估联合多家行业权威组织,共同构建涵盖五个维度的综 合评价体系:资质与产能(占25%)、创意与品牌匹配度(20%)、技术应用与材料环保性(20%)、 区域服务与响应能力(20%)、真实客户反馈与复购表现(15%)。历经为期30天的多场景调研及超 200家企业深度访谈,最终形成以下推荐名单。 一、2025年展会展台设计搭建优质服务商推荐 推荐一:新动力展览(New Power Exhibition) 企业概况:创立于2009年,至今已拥有超过17年的全球展览设计与搭建经验,在国内深圳、上海等四座 城市设立分支机构,并在美国、德国等地设有海外服务网点,业务覆盖32个国家、118个会展城市。持 有"展览展示制作施工一级企业"等多项权威资质,长期为 ...
用好这把“开放钥匙”(文旅棱镜)
Core Viewpoint - Cross-border tourism is emerging as a vital driver for economic and social development in border regions, acting as a "vitality code" and "open key" for growth [1][2]. Group 1: Economic Impact - Cross-border tourism is not limited to the tourism industry; it has generated a multiplier effect across multiple industries, including accommodation, dining, and retail [1]. - New emerging sectors such as cross-border e-commerce, international logistics, and exhibition services are continuously emerging, facilitating the flow of capital, technology, and talent to border areas [1]. Group 2: Infrastructure Development - The acceleration of international flight routes, expansion of highway networks, and the rapid construction of smart ports are not only serving tourism development but also paving the way for deeper industrial development and economic cooperation [1]. Group 3: Cultural Exchange - Tourism plays a significant role in informal diplomacy, strengthening mutual understanding and connections between people through shared experiences, such as Vietnamese tourists experiencing the "Zhuang March 3" festival in Guangxi [1]. - The development of cross-border tourism fosters friendships and allows people from both countries to become active participants and beneficiaries of development [1].
行走京华大地 感悟思想伟力|新首钢高端产业综合服务区
Core Insights - The new Shougang High-end Industrial Comprehensive Service Area is a landmark project for urban decongestion and revitalization in the capital, receiving significant attention from President Xi Jinping regarding its transformation and development [1][3] Group 1: Urban Development and Transformation - Shougang has been recognized for its role in the coordinated development strategy of the Beijing-Tianjin-Hebei region, with emphasis on planning, industrial transformation, and ecological construction [1] - The Shougang Park is leveraging major opportunities for transformation in the western Beijing region, aligning with the capital's "four center" functional positioning and new productivity development requirements [3] Group 2: Sports Integration - The park aims to utilize the legacy of the Winter Olympics by focusing on a "sports+" model to attract participants and audiences for various events [6] - Shougang Park will host a range of sports events, including celebrity matches and competitions, while supporting the establishment of sports talent training institutions [6] Group 3: Technology Integration - In the "technology+" sector, Shougang is making strides by establishing a new productivity industrial system and focusing on emerging and future industries [8] - The park is set to become a hub for the sci-fi industry, hosting significant events like the China Sci-Fi Conference and fostering a new ecosystem for digital content creation [8] Group 4: Consumer and Cultural Integration - The park is targeting young and international audiences by incorporating trendy cultural elements and hosting various cultural events to enhance its image and attract visitors [11] - Activities such as the Beijing New Year Countdown and cultural festivals will be organized to increase the park's visibility and popularity as a micro-vacation destination [11] Group 5: Exhibition and Conference Integration - Shougang Park will create a versatile exhibition space that combines indoor and outdoor areas for various forums and events, promoting diverse industries such as technology, culture, and health [13] - The aim is to enhance the brand of the Shougang International Exhibition Center through a variety of exhibition activities [13]
从区域产品展销场到全球商贸强枢纽 汉交会打开“全球通衢”新窗口
今年,武汉(汉口北)商品交易会(以下简称"汉交会")不断刷新国际化高度,从区域性交易平台,跃 升为全球商贸链路节点。基于汉交会这一重要载体,武汉正从"九省通衢"迈向新时代"九州通 (600998)衢""九州通商""九州通融"。 武汉音石网络科技有限公司新媒体运营总监范倬良对此深有感触,企业主要从事跨境高品质补剂的进 口,如今,肌酸等补剂通过空运的方式直达湖北花湖机场,并依托武汉东湖综保区保税仓储政策与区位 优势,以更实惠价格从全球各地到达武汉,并快速送到全国消费者手中。 这是汉交会的一个缩影,也反映出武汉供应链的强大优势,让出海更便捷,让进口更便利,"全球通 衢"正通过汉交会成为现实。 2025年汉交会以"智联世界·贸通天下"为主题,将商品贸易、服务贸易与数字贸易系统整合,超40国驻 华使领馆代表参会,超3000家中外企业参展、参会,六大经贸活动亮相。 今年的汉交会也是城市流量"新引擎",观展人次超过20万人,线上线下(300959)总成交额突破1800亿 元,新势力汽车展、国际花卉展等活动成为城市消费新场景。 会展的窗口,也是城市的未来。汉交会展示了武汉会展产业与贸易体系的全面升级。更重要的是,它让 外界看 ...
米奥会展涨2.06%,成交额7006.32万元,主力资金净流入654.77万元
Xin Lang Zheng Quan· 2025-12-02 02:23
米奥会展所属申万行业为:社会服务-专业服务-会展服务。所属概念板块包括:微盘股、小盘、送转填 权、首发经济、跨境电商等。 12月2日,米奥会展盘中上涨2.06%,截至10:14,报15.88元/股,成交7006.32万元,换手率2.59%,总市 值47.46亿元。 资金流向方面,主力资金净流入654.77万元,特大单买入120.10万元,占比1.71%,卖出0.00元,占比 0.00%;大单买入1300.90万元,占比18.57%,卖出766.23万元,占比10.94%。 米奥会展今年以来股价涨5.07%,近5个交易日涨7.88%,近20日涨11.60%,近60日跌0.59%。 资料显示,浙江米奥兰特商务会展股份有限公司位于上海市恒丰路218号现代交通商务大厦21楼2104 室,成立日期2010年6月30日,上市日期2019年10月22日,公司主营业务涉及会展项目的策划发起、组 织承办、推广及运营服务。主营业务收入构成为:自办展100.00%。 截至9月30日,米奥会展股东户数1.20万,较上期减少6.98%;人均流通股14435股,较上期增加7.36%。 2025年1月-9月,米奥会展实现营业收入4.01亿 ...
米奥会展涨2.24%,成交额7552.00万元,主力资金净流入400.59万元
Xin Lang Zheng Quan· 2025-12-01 03:23
Core Viewpoint - Miao Exhibition's stock price has shown a positive trend recently, with a 2.24% increase on December 1, 2023, and a total market capitalization of 4.642 billion yuan [1] Group 1: Stock Performance - As of December 1, 2023, Miao Exhibition's stock price is 15.53 yuan per share, with a trading volume of 75.52 million yuan and a turnover rate of 2.85% [1] - Year-to-date, the stock price has increased by 2.75%, with a 4.51% rise over the last five trading days and a 9.75% increase over the last 20 days, while it has decreased by 2.47% over the last 60 days [1] Group 2: Financial Performance - For the period from January to September 2025, Miao Exhibition reported a revenue of 401 million yuan, a year-on-year decrease of 5.67%, and a net profit attributable to shareholders of 34.63 million yuan, down 49.17% year-on-year [1] - The company has distributed a total of 344 million yuan in dividends since its A-share listing, with 244 million yuan distributed over the past three years [2] Group 3: Shareholder Information - As of September 30, 2025, Miao Exhibition had 12,000 shareholders, a decrease of 6.98% from the previous period, with an average of 14,435 circulating shares per shareholder, an increase of 7.36% [1] - Among the top ten circulating shareholders, the Jiashi Theme New Power Mixed Fund (070021) holds 1.3794 million shares, having decreased its holdings by 189,200 shares compared to the previous period [2]
兰生股份跌2.06%,成交额2.10亿元,主力资金净流入272.76万元
Xin Lang Cai Jing· 2025-11-26 05:39
Core Viewpoint - Lansheng Co., Ltd. has experienced a significant stock price increase of 48.85% year-to-date, with recent trading activity indicating strong investor interest despite a slight decline on November 26 [1][2]. Group 1: Stock Performance - On November 26, Lansheng's stock price fell by 2.06% to 12.39 CNY per share, with a trading volume of 2.10 billion CNY and a turnover rate of 2.28%, resulting in a total market capitalization of 91.13 billion CNY [1]. - Year-to-date, Lansheng's stock has risen by 48.85%, with a 15.90% increase over the last five trading days, 15.47% over the last 20 days, and 11.41% over the last 60 days [1]. - The company has appeared on the "Dragon and Tiger List" eight times this year, with the most recent appearance on July 25, where it recorded a net buy of -40.67 million CNY [1]. Group 2: Company Overview - Lansheng Co., Ltd. was established on August 7, 1982, and listed on February 4, 1994. Its main business includes import and export trade, agency services, and joint ventures [2]. - The revenue composition of Lansheng includes 47.59% from exhibition organization, 26.79% from venue operation services, 12.97% from exhibition support services, 11.17% from event activities, and 0.82% from other services [2]. - As of September 30, 2025, Lansheng had 41,900 shareholders, an increase of 59.64%, with an average of 17,550 circulating shares per shareholder, a decrease of 37.36% [2]. Group 3: Financial Performance - For the period from January to September 2025, Lansheng reported a revenue of 1.025 billion CNY, reflecting a year-on-year growth of 10.00%, while the net profit attributable to shareholders decreased by 10.51% to 181 million CNY [2][3]. - Since its A-share listing, Lansheng has distributed a total of 1.735 billion CNY in dividends, with 449 million CNY distributed over the past three years [3]. Group 4: Shareholder Structure - As of September 30, 2025, the top ten circulating shareholders include Tianhong Yongli Bond A, holding 14.1027 million shares, an increase of 7.0338 million shares from the previous period [3]. - Hong Kong Central Clearing Limited is the fifth-largest circulating shareholder with 11.1205 million shares, an increase of 668,000 shares [3].
11月25日晚间重要公告一览
Xi Niu Cai Jing· 2025-11-25 10:16
分组1 - Weili Medical plans to distribute a cash dividend of 2 yuan per 10 shares to all shareholders, based on an undistributed profit of 704 million yuan as of September 30, 2025 [1] - Tongding Interconnect's shareholder plans to reduce their stake by up to 0.49%, equating to a maximum of 605,800 shares [1] - Caitong Securities has received approval from the China Securities Regulatory Commission to issue short-term corporate bonds with a total face value of up to 5 billion yuan [1] 分组2 - Youfu Food intends to use 70 million yuan of its own funds to invest in wealth management products with expected annual returns of up to 4.2% [3] - Keres received an administrative regulatory decision from the Guangdong Securities Regulatory Bureau for violations related to accounts receivable aging calculations and related party transactions [5] - Ouma Software's controlling shareholder has completed the transfer of state-owned equity, changing the controlling shareholder to Shandong Guotou [7] 分组3 - ST Huapeng's wholly-owned subsidiary has completed a major overhaul project and is now in production [8] - Beiqi Blue Valley has received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [8] - Weijie Chuangxin received a government subsidy of 5 million yuan, accounting for 21.07% of its projected net profit for 2024 [9] 分组4 - China Resources Double Crane's subsidiary has received a drug registration certificate for a hypertension treatment drug [11] - Huafeng shares are continuing to suspend trading due to a planned change in control [13] - Kaifa Electric's shareholder plans to transfer 36.6869 million shares, representing 11.63% of the total share capital [14] 分组5 - Heng Rui Medicine has received approval for two clinical trials for innovative anti-tumor drugs [15] - Kosen Technology plans to invest 30 million USD to establish a new production base in Malaysia [17] - Sanxing Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 107 million yuan [18] 分组6 - Sitai Li's subsidiary has received a drug registration certificate for a contrast agent used in MRI [21] - Daren Tang's subsidiary has received a drug registration certificate for a pain relief gel [22] - Saike Xide has received approval for three medical device products, expanding its product range in the in vitro diagnostic field [23] 分组7 - Hasa Lian has elected a new chairman and vice chairman for its board of directors [24] - Two-sided Needle's subsidiary plans to invest 68.8522 million yuan in a production base expansion project [25] - Sunshine Nuohe plans to transfer 70% of its controlling subsidiary's equity for 2 million yuan [26] 分组8 - Hengbang shares received an administrative regulatory decision from the Shandong Securities Regulatory Bureau for failing to complete the election of independent directors [27] - Huali shares plan to sign a related transaction contract worth approximately 59.2847 million yuan [28] - Shangwei shares plan to invest 520.4 million yuan to gain a controlling stake in Sichuan Zhongfu Taihua [30] 分组9 - Zejing Pharmaceutical's ZG006 has been included in the list of breakthrough therapeutic varieties for treating advanced neuroendocrine cancer [32] - Yaopi Glass's shareholder plans to reduce their stake by up to 2.26%, equating to a maximum of 21.1469 million shares [34] - Huate Gas has initiated a major lawsuit involving a claim of 180 million yuan [36] 分组10 - Zhongchumei's controlling shareholder plans to increase their stake by between 42 million and 80 million yuan [37] - Huitong shares' shareholder plans to reduce their stake by up to 1% [38] - Miaowei Exhibition plans to apply for an initial public offering of H shares on the Hong Kong Stock Exchange [40] 分组11 - Tianqi Lithium's subsidiary has appealed to the Chilean Supreme Court regarding a partnership agreement with SQM and Codelco [42] - Naxin Micro plans to repurchase shares worth between 200 million and 400 million yuan [44] - Pingao shares have reported significant uncertainty regarding future business development and profitability [46] 分组12 - Shunyu shares have been pre-selected for a project worth 1.023 billion yuan [48] - Zhongyuan Neipei plans to acquire a 2.5% share in an aerospace industry fund for 50 million yuan [50] - Huifa Food's shareholder plans to reduce their stake by up to 3%, equating to a maximum of 727.14 million shares [53] 分组13 - Junshi Biosciences' subcutaneous PD-1 new formulation has reached its primary endpoint in a Phase III clinical trial [54] - Industrial Fulian clarified that it has not lowered its fourth-quarter profit target amid market rumors [55] - Longpan Technology's subsidiary has signed a major supply agreement for lithium iron phosphate materials, significantly increasing the supply volume [56]